|8730 Stony Point Parkway, Suite 205 , Richmond, VA 23235|
|Fund Manager||Kevin Miller|
|Manager Tenure||5 Years 3 Months|
The E-Valuator Aggressive Growth (85%-99%) RMS (Risk-Managed Strategy) Fund (the Fund seeks to provide growth of principal within the stated asset allocation range. The Fund seeks to achieve its objective by investing, under normal market conditions, in the securities of other unaffiliated investment companies, including open-end funds, exchange-traded funds ( ETFs ) and closed-end funds (collectively referred to as Underlying Funds. The Fund utilizes a risk-managed strategy (thus, the term RMS in the Fund s name), which involves the allocation of invested assets across multiple underlying investments in a manner that attempts to limit fluctuations in annualized returns that would be commensurate to an investor seeking to experience very low volatility as measured by standard deviation. An investments volatility is commonly measured by standard deviation. Standard deviation provides the probable range of anticipated returns based on the performance fluctuations over previous time periods (1-year, 3-year, or 5-year).Investments with the lowest levels of standard deviation would be considered very conservative (less volatile), while investments with higher levels of standard deviation would be considered more growth oriented and aggressive in nature (more volatile). The strategy of this Fund is to keep the level of annualized performance fluctuation within standard deviation parameters that would be suitable for an aggressive growth oriented investor, therefore being the most volatile investment of the funds within the family of funds comprising the E-Valuator Funds. The standard deviation goal forth Fund is to average between 9.5% to 13.5% over a 3-year time frame or a 5-year time frame. The Fund allocates assets across three broad asset classes (money market, bonds, equities) in a manner that provides a high probability of meeting the accepted standard deviation goals. The Fund will generally allocate 1%-15% of its assets into a variety of Underlying Funds that focus on investments in fixed income securities ( e.g. ., money markets and bonds) that possess varying qualities of credit and duration including high-yield securities (also referred to as junk bonds). The remaining 85%-99% of the Funds assets will generally be allocated to equity securities that have the potential of providing dividends and growth on an annual basis. The equity allocation will be invested in Underlying Funds that invest in U.S. and foreign securities (including emerging markets securities) and that focus on investments without regard to market capitalization (i.e., investments may include securities of issuers that would be considered small, medium and/or large capitalization companies).The Fund identifies an emerging market security based on it being placed in the Diversified Emerging Market equity category by Morning star, Inc.
|Asset Type||% Of Allocation|
|Total Net Assets||14.10 M|
|Criteria||3 Years||5 Years||10 Years|
|Minimum Initial IRA||$10000|
|Timeframe||Average Annual Current Performance Monthly As Of 08/31/2021||Average Annual Current Performance Quarterly As Of 06/30/2021||Avg Annual Current Performance Monthly As Of 08/31/2021||Avg Annual Current Performance Quarterly As Of 06/30/2021|
|Life Of Fund||
|Symbol||Company Name||% Of Assets|
|SWPPX||SCHWAB S&P 500 FUND||5.43%|
|SCHD||SCHWAB US DIVIDEND EQUITY||5.33%|
|SCHG||SCHWAB US LARGE CAP GR ETF||4.63%|
|VWIGX||VANGUARD INTERNATIONAL GR||3.40%|
|JVAL||JPMORGAN US VALUE FACTOR ETF||3.29%|
|VLU||SPDR S&P 1500 VALUE TILT ETF||3.29%|
|HFLYX||HARTFORD FLOATING RATE FD C Y||3.07%|
|SPDW||SPDR PTF DEV WORLD EX-US ETF||2.98%|
|VV||VANGUARD LARGE CAP VIPERS||2.93%|
|FPMIX||FIDELITY EMERG MKT INDEX FUND||2.81%|
Join the Action Alerts PLUS Community today!
AstraZeneca's breast-cancer treatment reduced the risk of disease progression or death by 72% vs. a currently approved treatment.
Bitcoin and other cryptocurrencies are battered as China Evergrande Group struggles with bond obligations.
Brooks Automation is selling its chip solutions group and said it would no longer pursue splitting into two companies.
DR Horton said "significant disruptions in the supply chain ... along with tightness in the labor market" will lead to a modestly lower full-year sales forecast.
Colgate-Palmolive stock was upgraded to buy with an $86 price target at Deutsche Bank.
Jim Cramer discusses the market selloff, Evergrande, debt ceiling talks, the upcoming Federal Reserve meeting, Pfizer and more in his latest video interview with TheStreet.
Wynn Resorts faces regulatory uncertainty in Macau, but Morgan Stanley says the casino operator is still 'worth the risk.'
Tesla wants to expand its autonomous-driving effort to help cars make their way through cities, not just highways.
Stocks moving in premarket trading Monday include Pfizer, Netflix, Li Auto, AstraZeneca and Bank of America.
'Lehman moment' or managed failure? Either result has global markets rattled by the impending default of property developer China Evergrande.